Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jiehui Cai"'
Autor:
Zeqi Ji, Lingzhi Chen, Qiuping Yang, Huiting Tian, Jinyao Wu, Daitian Zheng, Jiehui Cai, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology. 12
BackgroundRecently, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC. This paper aims to use bibliometric analysis to investigate the research status and future
Autor:
Jinyao Wu, Yaokun Chen, Lingzhi Chen, Zeqi Ji, Huiting Tian, Daitian Zheng, Qiuping Yang, Yiyuan Liu, Jiehui Cai, Jiehua Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology. 12
In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day i
Autor:
Taofeng Zhang, Yihuan Chen, Weixun Lin, Jiehua Zheng, Yiyuan Liu, Juan Zou, Jiehui Cai, Yaokun Chen, Zhiyang Li, Yexi Chen
Publikováno v:
Frontiers in Genetics
Frontiers in Genetics, Vol 12 (2021)
Frontiers in Genetics, Vol 12 (2021)
Thyroid cancer (THCA) is a common endocrine malignancy. With increasing incidence and low mortality, balancing the therapeutic approach is an inevitable issue. This study aimed to confirm the role of miR-222-3p and its target genes in THCA survival a
Autor:
Shangbo Xu, Yiyuan Liu, Taofeng Zhang, Jiehua Zheng, Weixun Lin, Jiehui Cai, Juan Zou, Yaokun Chen, Yanna Xie, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast cancer incidences, deaths, and disability-adjusted life-years (DALYs